tebuconazole has been researched along with Plague in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alldredge, MW; Bevins, SN; Boyce, WM; Boydston, EE; Crooks, KR; Fisher, RN; Franklin, SP; Gage, KL; Krumm, C; Logan, KA; Lyren, LM; Macmillan, ML; Riley, SP; Roelke, ME; Salman, M; Schmit, VL; Schriefer, ME; Sweanor, LL; Tracey, JA; Vandewoude, S; Vickers, W | 1 |
Powell, B; Rocke, TE; Shenk, TM; Wolfe, LL | 1 |
Shenk, TM; Spraker, TR; Wild, MA | 1 |
3 other study(ies) available for tebuconazole and Plague
Article | Year |
---|---|
Wild felids as hosts for human plague, Western United States.
Topics: Animals; Antibodies, Bacterial; Colorado; Disease Reservoirs; Humans; Lynx; Plague; Puma; Seroepidemiologic Studies; Yersinia pestis | 2009 |
Assessment of a recombinant F1-V fusion protein vaccine intended to protect Canada lynx (Lynx canadensis) from plague.
Topics: Animals; Antibodies, Bacterial; Case-Control Studies; Conservation of Natural Resources; Female; Lynx; Plague; Plague Vaccine; Recombinant Fusion Proteins; Vaccines, Synthetic; Yersinia pestis | 2011 |
Plague as a mortality factor in Canada lynx (Lynx canadensis) reintroduced to Colorado.
Topics: Animals; Colorado; Conservation of Natural Resources; Female; Fluorescent Antibody Technique; Lynx; Plague; Yersinia pestis | 2006 |